A functional measurement of MAPK pathway activation to predict response to MEK inhibitors in RAS-mutated patients.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Shumei Kato, Robert Porter, Ryosuke Okamura, Ori Zelichov, Gabi Tarcic, Michael Vidne, Razelle Kurzrock
Institutions: University of California San Diego, Moores Cancer Center
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2947153910